Document:

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

Intellectual Property License Agreement

 

This Intellectual Property License Agreement (“Agreement”), entered into and effective as of October 8, 2020 (the “Effective Date”), is made by and between Orthogonal Thinker, Inc., a corporation organized under the laws of the State of Delaware (“Licensor”), and Ei.Ventures, Inc., a corporation organized under the laws of the State of Delaware (“Licensee”) (collectively, the “Parties,” or each, individually, a “Party”).

 

WHEREAS, Licensor and Licensee are affiliated entities;

 

WHEREAS, Licensor owns the Licensed Intellectual Property (as defined below);

 

WHEREAS, Licensee wishes to develop, commercialize, use and practice the Licensed Intellectual Property; and

 

WHEREAS, Licensor is willing to grant to Licensee a license to the Licensed Intellectual Property.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

 

1.Definitions. 

 

1.1Affiliate or Affiliates. “Affiliate” or “Affiliates” shall mean, with respect to any Party, any Person that controls or is controlled by or is under common control with such Party, where “control” means the possession or the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of a majority of the outstanding voting securities or otherwise. 

 

1.2Intellectual Property. “Intellectual Property” shall mean all intellectual property, including but not limited to the following: (a) all inventions (whether patentable or unpatentable and whether or not reduced to practice), and all patents, patent applications, and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions, re-examinations and foreign counterparts thereof; (b) all trademarks, service marks, trade dress, logos, slogans, trade names, corporate names, internet domain names, and rights in telephone numbers, together with all translations, adaptations, derivations, and combinations thereof and including all goodwill associated therewith; (c) all copyrightable works, all copyrights, and all applications, registrations, and renewals in connection therewith; (d) all mask works and all applications, registrations, registrations, and renewals in connection therewith; (e) all trade secrets and confidential business information (including ideas and research and development, Know-How, formulas, compositions, manufacturing and production processes and techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information, business and marketing plans and proposals); (f) all computer software (including but not limited to source code, object code, data, databases, and related documentation); (g) all advertising and promotional materials; (h) all other proprietary rights; and (i) all copies of tangible embodiments thereof (in whatever form or medium). 

 

1.3Know-How. “Know-How” shall mean any and all technical information, both presently available at the Effective Date of this Agreement and hereafter developed or acquired, that relates to Products and shall include, without limitation, all manufacturing data and any other information relating to Products and useful for the development, manufacture, or effectiveness of Products. 

 

1.4Licensed Field. “Licensed Field” shall mean medicinal, therapeutic, nutraceutical, and adult recreational uses 

 

1.5Licensed Intellectual Property. “Licensed Intellectual Property” shall mean the Intellectual Property set forth on Schedule A, as it may be from time to time amended and updated as set forth herein. 

1

1.6Person. “Person” shall mean an individual, corporation, partnership, trust or any other form of entity. 

 

1.7Product. “Product” shall mean any tangible or intangible item or service manufactured, sold, distributed, or licensed by or for the Licensee that incorporates, utilizes, or is made using any of the Licensed Intellectual Property in the Licensed Field. 

 

1.8Third Party or Third Parties. “Third Party” or “Third Parties” shall mean any entity other than a party to this Agreement or an Affiliate. 

 

2.License. 

 

2.1License Grant. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee during the Term (as defined below) an exclusive, non-transferable, royalty-free, worldwide, sublicensable (subject to the restrictions set forth herein) license to use and practice the Licensed Intellectual Property solely in the Licensed Field, including, without limitation, rights to make, have made, reproduce, distribute, design, develop, advertise, promote, sell, import, export, modify or otherwise exploit, directly or through subsidiaries and/or sublicensees, Products. 

 

2.2Right to Sublicense. The license granted in Section 2.1 includes the right to grant nonexclusive sublicenses. Such sublicenses may only be granted to Affiliates of the Parties (each such Affiliate sublicensee, a “Sublicensee”), further provided that: (1) each such Sublicensee shall agree to be subject to the terms of this Agreement in its entirety, (2) no such sublicense shall impair Licensee (directly or with and through its Sublicensees) to perform its obligations hereunder, (3) no such sublicense shall limit or impair Licensor’s rights hereunder, (4) Licensee shall remain responsible for its and its Sublicensees’ conformity to the terms and conditions set forth herein, including without limitation, the obligation to make payments as and when due hereunder, and the obligation to keep records and make reports hereunder, and (5) each such sublicense will require the written approval of Licensor, which will not be unreasonably withheld. Licensee shall provide Licensor with a true, accurate and complete copy of each sublicense agreement with its Sublicensees promptly after execution. Each sublicense granted to a Sublicensee by Licensee to any rights licensed to it hereunder shall terminate immediately upon the termination of the license from Licensor to Licensee with respect to such rights as of the effective date of such termination. 

 

2.3Reservation of Rights. Licensor hereby reserves all rights not expressly granted to Licensee under this Agreement. 

 

3.Quality Control. 

 

3.1Quality Standards. 

 

(a)Product sold by Licensee shall meet the quality control standards and specifications established from time to time by Licensor, including any requirements of applicable regulatory agencies. Licensor shall have the right to audit Licensee’s quality control of Product from time to time on a reasonable basis and on reasonable prior notice to Licensee. 

 

(b)In the event that quality control of Licensee falls below Licensor’s standards and specifications, Licensor shall give Licensee written notice of such failures, and Licensee shall, at its expense and within the reasonable notice period set out in the notice, take such corrective action as is necessary to restore quality to the appropriate level. 

 

3.2Use of Marks. Licensee shall comply with Licensor’s guidelines and specifications regarding the style, appearance, and usage of all marks included with the Licensed Intellectual Property. Licensee shall use proper notice symbols and legends as may be required under applicable law to maintain such marks and Licensor’s rights therein. All goodwill associated with such marks shall insure to the benefit of, and be the exclusive property of, Licensor. 

2

4.Ownership and Protection of the Licensed Intellectual Property. 

 

4.1Acknowledgment of Ownership. Licensee acknowledges that, as between Licensee and Licensor, Licensor owns and will retain all right, title, and interest in and to the Licensed Intellectual Property. All use by Licensee or any sublicensee of the Licensed Intellectual Property, and all goodwill accruing therefrom, will inure solely to the benefit of Licensor. All improvements to the Licensed Intellectual Property (“Improvements”) shall be the property of Licensor and if title to such improvements does not vest in Licensor at conception or creation, then Licensee hereby assigns all such improvements to Licensor. Improvements shall constitute Licensed Intellectual Property and shall be added to Schedule A. Licensee shall promptly disclose all Improvements to Licensor. 

 

4.2Enforcement. Licensee shall promptly notify Licensor in writing of any actual, suspected, or threatened infringement, dilution, or other conflicting use of the Licensed Intellectual Property by any third party of which it becomes aware. Licensor has the sole right, in its discretion, to bring any action or proceeding with respect to any such infringement, dilution, or other conflict and to control the conduct of any such action or proceeding (including any settlement thereof). Licensee shall provide Licensor with all assistance that Licensor may reasonably request, at Licensor’s expense, in connection with any such action or proceeding. Licensor will be entitled to retain any monetary recovery resulting from any such action or proceeding (including any settlement thereof) for its own account. 

 

4.3Intellectual Property Prosecution and Maintenance. 

 

(a)Beginning on the Effective Date, all present and future costs of preparing, filing, prosecuting, registering, defending, and maintaining all Licensed Intellectual Property shall be borne by Licensee. Licensee shall be informed in advance of any such undertakings and be given an opportunity to review them to the extent reasonably possible. Licensee shall pay all invoices for such expenses sent by Licensor or Licensor within sixty (60) days of invoice date. Licensee’s obligation for expense reimbursement shall cover all Licensed Intellectual Property, including without limitation, all Improvements. 

 

(b)Unless stated otherwise in this Agreement, Licensor shall be the named and record owner of all Licensed Intellectual Property, and shall have final authority over selection of intellectual property attorneys and all decisions with respect to preparing, filing, prosecuting, registering, defending, or maintaining all Licensed Intellectual Property, but shall have no obligation to make such filings if, in the exercise of its authority and discretion, declines to do so. 

 

5.Indemnification. 

 

(a)By Licensee. Licensee shall indemnify, defend, and hold harmless Licensor, its affiliates, officers, directors, employees, agents, and representatives against all losses, liabilities, claims, damages, actions, fines, penalties, expenses, or costs (including court costs and reasonable attorneys’ fees) (“Losses”) arising out of or in connection with any third-party claim, suit, action, or proceeding relating to: (a) any breach of this Agreement by Licensee; or (b) any alleged action, or failure to act, on the part of Licensee. 

 

(b)By Licensor. Licensor shall defend and hold harmless Licensee, its affiliates, officers, directors, employees, agents, and representatives against Losses arising out of or in connection with any third-party claim, suit, action, or proceeding relating to: (a) any breach of this Agreement by Licensor; or (b) any alleged action, or failure to act, on the part of Licensor. 

 

6.Representations and Warranties. Each Party represents and warrants to the other that: (a) it is a legally organized entity in good standing; and (b) it has the right and authority to enter into this Agreement. 

3

7.Disclaimer; Limitation of Liability. 

 

7.1Disclaimer. EXCEPT AS SET FORTH IN THE PRECEDING SECTION, EACH PARTY EXPRESSLY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, IN CONNECTION WITH THIS AGREEMENT AND THE LICENSED INTELLECTUAL PROPERTY, INCLUDING ANY WARRANTIES OF TITLE, NON-INFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, LICENSOR MAKES NO REPRESENTATION OR WARRANTY THAT ANY LICENSED INTELLECTUAL PROPERTY IS VALID OR THAT THE EXERCISE BY LICENSEE OF ANY RIGHTS GRANTED UNDER THIS AGREEMENT WILL NOT INFRINGE THE RIGHTS OF ANY PERSON. 

 

7.2Limitation of Liability. EXCEPT FOR A PARTY’S LIABILITY FOR INDEMNIFICATION UNDER SECTION 6, NEITHER PARTY WILL BE LIABLE TO THE OTHER PARTY OR ANY THIRD PARTY FOR ANY CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY, SPECIAL, OR PUNITIVE DAMAGES RELATING TO THIS AGREEMENT OR USE OF THE LICENSED MARKS HEREUNDER, WHETHER ARISING OUT OF BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE, REGARDLESS OF WHETHER SUCH DAMAGE WAS FORESEEABLE AND WHETHER SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 

 

8.Term and Termination. 

 

8.1Term. This Agreement begins on the Effective Date and will remain in force until terminated in accordance with its terms. 

 

8.2Termination by Licensor. Licensor may terminate this Agreement immediately upon written notice to Licensee if Licensee materially breaches this Agreement and fails to cure such breach within thirty (30) days after receiving written notice thereof. 

 

8.3Termination by Licensee. Licensee may terminate this Agreement immediately upon written notice to Licensor if Licensor materially breaches this Agreement and fails to cure such breach within thirty (30) days after receiving written notice thereof. 

 

8.4Other. Either Party shall have the right to terminate this Agreement at any time, by giving written notice to the other Party on the occurrence of any of the following events: 

 

(a)Any act, determination, filing, judgment, declaration, notice, appointment of receiver or trustee, failure to pay debts, or other events under any law applicable to a Party indicating the insolvency or bankruptcy of such Party; or 

 

(b)Any extraordinary governmental action, including, without limitation, seizure or nationalization of assets, stock, or other property relating to a Party. 

 

8.5Rights and Duties on Termination. Upon termination of this Agreement: 

 

(a)Licensor shall have the right to retain any sums already paid by Licensee under this Agreement, and Licensee shall pay all sums accrued that are then due under this Agreement; and 

 

(b)Licensee shall discontinue all use of the Licensed Intellectual Property and shall have no further right, title, or interest in the Licensed Intellectual Property. 

4

9.Confidential Information. 

 

9.1This Section 10 applies to all Confidential Information disclosed by the disclosing Party to the receiving Party. “Confidential Information” means confidential and proprietary information of a Party, whether in written, printed, verbal or electronic form, including, without limitation: (i) research and development activities, product design details and specifications, technology and know-how, sales and marketing plans, finances and business forecasts, procurement requirements and vendor information, customer lists, personnel information, and strategic plans; (ii) other information that the disclosing Party identifies in writing as confidential to the receiving Party; (iii) information that the receiving Party knows or has reason to know is confidential, trade secret, or proprietary information of the disclosing Party; and (iv) information which is of such a nature or the manner or circumstance in which such information is disclosed is such that it may be reasonably inferred to be confidential and/or proprietary to the disclosing Party. Confidential Information will not include information that: (v) is now, or hereafter becomes generally known or available to the public through no act or failure to act on the part of the receiving Party; (vi) was acquired by the receiving Party before receiving such information from the disclosing Party through no breach of any duty of confidentiality owed to the disclosing Party and without restriction as to use or disclosure; (vii) is hereafter rightfully furnished to the receiving party by a third Party without any breach of any duty of confidentiality owed to the disclosing Party and without restriction as to use or disclosure; or (viii) is information that the receiving Party can document was independently developed by the receiving Party without any use of the disclosing Party’s Confidential Information. Each Party agrees to hold the disclosing Party’s Confidential Information in confidence and not to disclose such Confidential Information to any other person or entity without the prior written consent of the disclosing Party. All Know-How and trade secrets of Licensor are Confidential Information of Licensor. 

 

9.2In the event a receiving Party is required to disclose Confidential Information of the disclosing Party by any applicable law, regulation, legal process, judicial order or by any applicable order or requirement of any governmental or regulatory authority, it may do so only to the extent required thereby; provided, however, that the receiving Party will (i) use reasonable efforts under the circumstances to provide advance notice to the disclosing Party of the required disclosure to allow the disclosing Party an opportunity to take steps to object to, prevent or limit its disclosure or obtain a protective or other similar order with respect to the required disclosure and (ii) restrict disclosure to only that portion of the Confidential Information that is required to be disclosed. 

 

10.General Provisions. 

 

10.1Amendments. No amendment to this Agreement will be effective unless it is in writing and signed by both Parties. 

 

10.2Binding Effect, Assignment. This Agreement shall be binding upon, and shall inure to the benefit of, the Parties hereto and their permitted assigns and successors-in-interest. 

 

10.3Counterparts. This Agreement may be executed in counterparts, each of which is deemed an original, but all of which together are deemed to be one and the same agreement. 

 

10.4Severability. If any term or provision of this Agreement is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability will not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. 

 

10.5Governing Law and Jurisdiction. This Agreement, and all matters arising out of or relating to this Agreement, are governed by, and construed in accordance with, the laws of the State of Delaware, without regard to the conflict of laws provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other than those of the State of Delaware. All actions concerning or arising out of this Agreement shall be brought in a state or federal court of competent jurisdiction in the state of Delaware, and the parties hereby submit to jurisdiction in such Courts for such purposes. 

 

10.6Waiver. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power, or privilege arising from this Agreement will operate or be construed as a waiver thereof, nor will any single or partial exercise of any right, remedy, power, or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power, or privilege. 

 

10.7Survival. Sections 1, 4-8, and 10 shall survive the termination or other expiration of this Agreement. 

5

10.8Notices. All correspondence or notices required or permitted to be given under this Agreement must be in writing and addressed to the other Party at its address set out below (or to any other address that the receiving Party may designate in writing from time to time). Each Party shall deliver all notices by personal delivery, nationally recognized overnight courier (with all fees prepaid), or email (with confirmation of transmission), or certified or registered mail (in each case, return receipt requested, postage prepaid). Except as otherwise provided in this Agreement, a notice is effective only (a) upon receipt by the receiving Party and (b) if the Party giving the notice has complied with the requirements of this Section. Such communications must be sent to the respective Parties at the following addresses (or at such other address for a Party as specified in a notice given in accordance with this Section 11.8): 

 

	If to Licensor:

	Address: Redacted

	 

	Email: Redacted

	 

	Attention: Redacted

	 

	 

	If to Licensee:

	Address: Redacted

	 

	Email: Redacted

	 

	Attention: Redacted

 

10.9Force Majeure. If the performance of any part of this Agreement by either Party, or of any obligation under this Agreement, is prevented, restricted, interfered with, or delayed by reason of any cause beyond the reasonable control of the Party liable to perform, unless conclusive evidence to the contrary is provided, the Party so affected shall, on giving written notice to the other Party, be excused from such performance to the extent of such prevention, restriction, interference, or delay, provided that the affected Party shall use its reasonable best efforts to avoid or remove such causes of non-performance and shall continue performance with the utmost dispatch whenever such causes are removed. When such circumstances arise, the Parties shall discuss what, if any, modification of the terms of this Agreement may be required to arrive at an equitable solution. 

 

10.10Assignment. Licensor may freely assign its rights and obligations under this Agreement. Licensee may not assign or transfer any of its rights or obligations under this Agreement without Licensor’s prior written consent. Any purported assignment or transfer in violation of this Section 10 will be void and of no force and effect. 

 

10.11Entire Agreement. This Agreement, including and together with any related exhibits, schedules, attachments, and appendices, constitutes the sole and entire agreement of Licensor and Licensee with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations, and warranties, both written and oral, regarding such subject matter. 

 

[REMAINDER LEFT BLANK]

6

IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed as of the Effective Date by their respective representatives thereunto duly authorized.

 

	 

	ORTHOGONAL THINKER, INC.

	 

	 

	 

	By

	/s/ Redacted

	 

	Name:

	Redacted

	 

	Title:

	President

	 

	 

	 

	EI.VENTURES, INC.

	 

	 

	 

	By

	/s/ Redacted

	 

	Name:

	Redacted

	 

	Title:

	President

 

7

SCHEDULE A

 

Licensed Intellectual Property

 

1.Formulations - 

 

a)Kue/Caine Formula 

[***]

 

b)HapSe Formula 

[***]

 

c)Mana Formula 

[***]

 

d)Brain Soup Formula 

[***]

 

e)Doser’s Choice Formula (for enhanced effects) 

[***]

 

f)Chronic Pain Relief Formula - 

[***]

 

g)My-D 

[***]

 

h)Rave It/It’s It 

[***]

 

2. Patents and patent applications –

 

a)

 

U.S. Patent Provisional Application No.: 62/992263

Filing Date: March 20, 2020

Title: PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF USING AND MAKING THE SAME

Inventor: Chester Watson

 

b) All patents and applications filed during the effective term of this Agreement. owned by Licensor, that disclose, claim, or contain subject matter comprising any of the Licensed Intellectual Property set forth on this Schedule A, as may be amended from time to time, including all patents, patent applications, and patent disclosures, together with all reissuances, continuations, continuations-in-part, revisions, extensions, re-examinations and foreign counterparts thereof.

8

3. Trademarks –

 

a)Ku/Caine 

b)Hap Se 

c)Mana 

d)Brain Soup 

e)Doser’s Choice 

f)Happy Sexy 

g)My-D 

h)Rave It/It’s It 

 

4. Know-How –

 

a) all of Licensor’s know-how and trade secrets related to the subject matter of the Licensed Intellectual Property.

9Cannabis Supply Agreement (RVV  RCC) -  FINAL Jan 22, 2019 (1)

PSILOCYBIN SUPPLY AGREEMENT

 

THIS AGREEMENT is made effective as of  August 13, 2020

 BETWEEN:

HAVN LIFE SCIENCES INC.

 

(the “Supplier”),

 

- and -

 

MYCOTOPIA

 

(the “Company”)

WHEREAS:

 

A.The Supplier is in the business of supplying the Materials (as defined herein), as permitted by Governmental Authorities, by brokering the sale of the Materials held by a third-party Licensed Dealer under the Act (“Third Party LD”) or by direct sale under the Havn DL (as defined herein); 

 

B.The Company is a specialty pharmaceutical company focused on the research, development and commercialization of novel therapeutics for unmet medical needs; and 

 

C.The Supplier desires to sell, through a Third Party LD or directly under the Havn DL, and the Company desires to purchase Material from the Supplier, through a Third Party LD or directly under the Havn DL, subject to receipt of all required licenses from Governmental Authorities, as further described herein. 

NOW THEREFORE, in consideration of the covenants and agreements herein contained, the Parties agree as follows:

1.Definitions 

 

In this Agreement, unless something in the subject matter or context is inconsistent therewith:

(a)“Act” means the Controlled Drugs and Substances Act, S.C. 1996, c. 19 and the regulations promulgated thereunder; 

(b)“Agreement” means this agreement, including its recitals and schedules, as amended from time to time; 

(c)“Applicable Law” means: 

 

(i)any applicable domestic or foreign law including any statute, subordinate legislation or treaty; and 

  

(ii)any applicable guideline, directive, rule, standard, requirement, policy, order, judgment, injunction, award or decree of a Governmental Authority; 

 

(d)“Batch” means the batch of Material from which any Material sold to and purchased by the Company pursuant to this Agreement was taken, derived, or obtained; 

(e)“Business Day” means a day other than a Saturday, Sunday or statutory holiday in the Province of British Columbia; 

(f)“Completion Date” means the first anniversary of the Effective Date, or such earlier date in accordance with the terms set out herein or later, as mutually agreed to in writing by the Parties; 

 

(g)“Confidential Information” means any proprietary information delivered by one Party to the other pursuant to this Agreement, including, but not limited to: 

 

(i)the commercial terms of this Agreement, including, without limitation, pricing of the Material and quantity of Material; 

 

(ii)any and all information of a technical, financial, accounting, tax, legal, commercial, operational or logistics nature related to the respective businesses of the Parties, including each Parties respective Intellectual Property; and 

 

(iii)the growing method (including nutrient, conditions, IPM, media for spawning, casing, pinning, and flushes), harvesting, drying, processing (including milling, grading), extraction (including solvents, concentrations and methods), testing, quality assurance, and record-keeping practices of the Supplier or the Company. 

 

Confidential Information shall not include any information:

 

(iv)which at the time of disclosure is readily available to the public; 

 

(v)which after disclosure becomes readily available to the public, other than through a breach of this Agreement; 

 

(vi)which is subsequently lawfully and in good faith obtained by the Party that does not own the information in question from an independent third party without breach of this Agreement; 

(vii)which the Party that does not own the information can establish was in such Party’s possession without obligation of confidentiality prior to the date of disclosure of such information by the disclosing Party to such recipient Party; or 

  

(viii)which is required to be disclosed by the Party that does not own the information in question by operation of law or regulation, provided such Party (if permitted by law) gives the disclosing Party prompt notice to allow the disclosing Party a reasonable opportunity to obtain a protective order therefor, with the exception of any request from Health Canada regarding the Material; 

 

(h)“Delivery Date” means the date of each shipment of Material from the Supplier to the Company in accordance with the delivery terms set out in Section 6; 

 

(i)“Effective Date” means the date first written above; 

(j)“Governmental Authority” means any domestic or foreign legislative, executive, judicial or administrative body, including Health Canada, or person having or purporting to have jurisdiction in the relevant circumstances; 

 

(k)“Havn DL” means a dealer’s license issued under the Act authorizing the Supplier to possess, manufacture and sell Materials; 

 

(l)“Intellectual Property” means intellectual property of any nature and kind in any jurisdiction throughout the world including but not limited to trademarks, business names, trade names, domain names, trading styles, patents, trade secrets, software, industrial designs, plant breeders’ rights, and copyrights, works of authorship or any other intangible right whether registered or unregistered, and all applications for registration thereof, and inventions, formulae, recipes, product formulations, processes and processing methods, technology and techniques and know-how;  

 

(m)“Licensing Date” means the date upon which the Supplier or the Third Party LD, as applicable, and the Company have received all necessary licenses and approvals from Governmental Authorities for the supply and purchase of Material as set out in this Agreement; 

 

(n)“Material” means the Psilocybin SPP product of the type and in the amount specified in Schedule A, as agreed to by the Parties from time to time, in writing; 

 

(o)“Party” means the Company, or the Supplier and “Parties” means both of them; 

 

(p)“Purchase Price” has the meaning set out in Section 4;  

(q)“Term” means the period of time beginning on the Licensing Date and ending upon the Completion Date unless terminated earlier in accordance with the terms of this Agreement; and 

(r)“Third Party LD” has the meaning set out in the recitals. 

 

2.Currency 

 

All references to currency herein are to lawful money of Canada.

3

  

3.Material to be Sold and Purchased 

During the Term, the Supplier will supply by brokering sale of the Materials from the Third Party LD or by directly selling the Materials to the Company and the Company will source the Materials from the Supplier directly or from the Third Party LD brokered by the Supplier on the terms and conditions set out in this Agreement.

4.Purchase Price 

 

(a)For any supply of Materials that includes brokerage by the Supplier from Third party LD, any applicable brokerage fees payable shall be added to the Purchase Price and shall be paid by the Company. 

 

(b)The Supplier shall broker supply from Third Party LD or, after issue of the Havn DL, supply the Materials to the Company, for the amounts as set out in Schedule A (the “Purchase Price”). 

 

5.Payment of Purchase Price 

 

The Purchase Price shall be paid as follows:

 

(a)50% of the Purchase Price for each shipment of Material will be payable to the Supplier on the earlier of: 

 

(i)the Delivery Date for such Material if such Material is being shipped to the Company immediately; or 

 

(ii)the date that the Company provides notice to the Supplier that it desires to purchase such Material from the Supplier, but does not want such Material to be shipped to the Company until a later date; and 

 

(b)50% of the Purchase Price will be payable 30 calendar days after the Delivery Date of the respective Material. 

 

6.Delivery Terms 

 

Subject always to Section 7:

 

(a)delivery shall occur on the Delivery Date at the Third Party LD’s premises or the Supplier’s premises, as applicable, with the Supplier responsible for all costs and risks associated with loading the Material onto freight service providers arranged by the Company; 

(b)delivery shall occur in compliance with all Applicable Laws; 

(c)to the extent additional permits are required to comply with Applicable Laws, the Company shall be responsible to acquire such permits and the Supplier shall cooperate and assist Company to acquire such permits, to the extent permitted under Applicable Law.  

4

  

(d)the Supplier will use, or shall cause the Third Party LD to use, as applicable, commercially reasonable efforts to ensure the Material is in good condition when it is delivered; 

(e)the Supplier will, or shall cause the Third Party LD to, as applicable, provide, at the cost of the Supplier, packaging materials and services in preparation for shipping the Material in a manner compliant with Applicable Law; 

(f)the Company will nominate, engage and coordinate freight services that are appropriate for the value of the Material. The Company will be responsible for all transportation and insurance costs; and 

 

(g)title to the Material, as well as risk of loss, shall pass to the Company once the Material is loaded by the Supplier or the Third Party LD, as applicable, onto the freight service provider arranged by the Company. 

 

7.Testing of Material Once Delivered to the Company 

 

(a)Within fifteen (15) Business Day after receipt of Material by the Company, the Company shall: (i) send a sample of each Batch of Material directly to the laboratories of Complex Biotech Discovery Ventures (“CBDV”) located at 3800 Wesbrook Mall, Vancouver, British Columbia V6S 2L9 or such other laboratory as agreed to by the Parties in writing (“Other Tester”), in order for such Material to be tested in accordance with the Act (“Testing”); and (ii) retain and store a second sample for archive purposes for period of two (2) years. All Testing, including, without limitation, courier costs associated with the sending of the sample to laboratories of Complex Biotech Discovery Ventures or an Other Tester upon by the Parties, shall be completed at the expense of the Company and the Company shall provide written copies of the results of each Testing (“Testing Results”) to the Supplier within five (5) Business Days of receipt by the Company of such Testing Results. 

 

(b)Subject to Section 7(c), if the Material does not pass the Testing set out in Section 7(a) successfully, as determined by CBDV or Other Tester, as applicable, with respect to such Batch of Material: 

(i)the Supplier shall be responsible to fully compensate the Company immediately by reimbursing the portion of the Purchase Price that was paid by the Company to the Supplier for the Material from that Batch; 

 

(ii)the remaining 50% of the Purchase Price that is unpaid by the Company for such Batch of Material shall immediately be forfeited by the Supplier and shall no longer be payable; and 

(iii)the Company shall re-deliver such Batch of the Material to the Supplier as soon as such delivery is approved by Health Canada and the shipping costs associated with such re-delivery shall be borne by the Supplier. Title to the Material, shall pass to the Supplier once the Material is loaded by the Company onto the freight service provider arranged by the Company. The Company will use commercially  

5

  

reasonable efforts to ensure the Material is in the same condition when it was delivered.

 

(c)For clarity, the Company may reject, in accordance with this Section 7, Material if the results of Testing indicate that the Material is not within acceptable ranges determined by a Governmental Authority for such Testing or if there is a discrepancy as to the Material’s content relative to information provided by the Supplier to the Company pursuant to Sections 10(f) and 11(d) hereto. 

 

8.The Company’s Representations and Warranties 

 

The Company represents and warrants to the Supplier (and confirms that such representations and warranties will be true as of each date that the Supplier ships Material to the Company) that:

 

(a)the Company is a corporation, duly incorporated and validly existing under the laws of the jurisdiction of its incorporation; 

 

(b)the Company is duly licensed or registered to carry on business in every jurisdiction in which such license or registration is required for purposes of this Agreement, except where the failure to be so licensed or registered, in the aggregate, would not reasonably be expected to adversely affect its ability to perform its obligations under this Agreement; 

 

(c)the Company has all required licenses under all Applicable Law necessary to engage in the contemplated activity, including without limitation the ability to engage in the purchase, sale and transportation of Material under the Act;  

 

(d)the Company has obtained all permits and/or licenses required by Applicable Laws to conduct its business generally and to exercise its rights and perform its obligations under this Agreement; 

 

(e)the Company all necessary corporate power and capacity to enter into this Agreement, grant the rights and licenses granted under this Agreement, and perform its obligations hereunder; 

 

(f)the execution of this Agreement by the Company’s representative whose signature is set forth at the end of this Agreement, and the delivery of this Agreement by the Company, have been duly authorized by all necessary corporate action on the part of the Company;  

 

(g)the execution, delivery and performance of this Agreement by the Company will not violate, conflict with, require consent under or result in any breach or default under (i) any of the Company’s organizational documents (including its articles of incorporation and by-laws), (ii) any Applicable Law or (iii) with or without notice or lapse of time or both, the provisions of any material contract of the Company;  

6

  

(h)when executed and delivered by the Company and the Supplier, this Agreement will constitute the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as may be limited by any applicable bankruptcy, insolvency, reorganization, arrangement, moratorium, or similar laws and equitable principles related to or affecting creditors' rights generally or the effect of general principles of equity; 

 

(i)the Company is in material compliance with all Applicable Laws relating to this Agreement and the operation of its business; 

 

(j)it is not insolvent and is paying all of its debts as they become due;  

 

(k)all financial information that it has provided to the Supplier is true and accurate and fairly represents the Company’s financial condition; and 

 

(l)the Company accepts ownership and all risk of loss associated with the Material once the Material is loaded onto the freight service provider, as per the terms set out in Section 6(e). 

 

9.Company’s Use of Supplier’s Trademarks and Brands 

The Company agrees to use the marks “Havn”, “Havn Life”, “Powered by Havn” or other such marks as identified by the Supplier, in accordance the Brand Standards and Use agreement to be provided by the Supplier.

 

10.Supplier’s Representations and Warranties 

 

The Supplier represents and warrants to the Company (and confirms that such representations and warranties will be true as of each date that the Material is shipped to the Company) that:

 

(a)all required licenses under all Applicable Law necessary to engage in the contemplated activity by or on behalf of the Supplier (including, the Third Party LD) shall have been obtained; 

 

(b)the Material has been produced and handled in compliance with the Act; and 

 

(c)the Material has undergone all required testing as outlined in the Act. 

 

11.Production Practices and Examination of Material and Records 

 

During the Term, the Supplier shall use commercially reasonable efforts to:

 

(a)within five (5) business days of a request by the Company, make available to the Company and its authorized representatives data recorded or stored by means of any device, including in electronic form, title documents, reports, studies, permits, licenses and other records in its possession or under its control relating to the Material, including documents relating to tracking, reproduction, inventory, seed transfer, Batch records, and any other  

7

  

documentation that the Supplier reasonably anticipates may be requested by Health Canada auditors. This obligation will persist for a period of six (6) months after the Completion Date;

(b)retain all records described in Section 10(a) for a period of six (6) months after the Completion Date and will also comply with all its obligations under the Act with respect to such records; 

(c)within five (5) business days of a request by the Company, provide the Company and its authorized representatives access to inspect the Material and the facility where the Material is produced prior to shipment of each Batch of Material, at the Company’s own cost, provided that that Company will not make such a request more than two (2) occurrences in a calendar year; 

 

(d)provide to the Company the results of all testing required under the Act; 

 

(e)provide monthly reports to the Company regarding the Material that the Supplier is cultivating and anticipates that it may have available to sell to the Company pursuant to the terms of this Agreement and keep the Company apprised of the status of such Material; and 

 

(f)use its commercially reasonable efforts to ensure that the Material available for purchase by the Company is Material that meets reasonable standards to allow the Company to use the product for resale without altering the form of the Material. 

 

12.Conditions of Closing for each Shipment of Material 

The sale by the Supplier or the Third Party LD, as applicable, and the purchase by the Company of the Material shall be subject to the following conditions, which are to be performed or complied with at or prior to each respective shipment of Material:

 

(a)the representations and warranties of each of the Supplier and the Company set forth in Sections 8 and 9 will be true and correct at each date that the Supplier or the Third Party LD, as applicable, ships Material to the Company with the same force and effect as if made at such time; 

(b)the Supplier will have performed or complied with all of its obligations of this Agreement to be performed or complied with by the Supplier at or prior to each monthly shipment date for the Material; 

(c)the Company will have confirmed that the Material is satisfactory to the Company and that all Testing and lot release documents are in order and meet its reasonable expectations in accordance with this Agreement; and 

(d)the Supplier, the Third Party LD, as applicable, and the Company will have received all required approvals from Health Canada pursuant to the Act authorizing the transaction or monthly shipments of Materials, as the case may be. 

8

  

The conditions set out in Section 12(a) (with respect to the Supplier’s representations and warranties only), 12(b) and 12(c) above are for the benefit of the Company and may be waived by the Company at any time. The condition set out in Section 12(d) may not be waived.

 

13.Termination 

 

This Agreement may be terminated at any time by either Party upon thirty (30) days written notice to the other Party.

 

By notice in writing prior to or on a scheduled Delivery Date for any shipment of Material, the Company may decide not to proceed with the purchase of Material in any month during the Term if any condition in Section 12(a) (with respect to the Supplier’s representations and warranties), 12(b), or 12(c) has not been satisfied as at such Delivery Date for the Material for that month and the Company has not waived such condition on or before such respective Delivery Date. Additionally, neither Party shall be required to proceed with a monthly shipment of Material if the condition set out in Section 12(d) has not been met on or before the scheduled Delivery Date.

 

14.Confidentiality 

 

During the Term and for a period of three (3) years thereafter, each of the Supplier and the Company agree to hold and maintain the Confidential Information of the other in the strictest confidence. Each of the Supplier and the Company shall divulge such Confidential Information only to its employees, agents, professional advisors or subcontractors and the Third Party LD, as applicable, who reasonably require access to such information for the purpose of performing this Agreement and who have been notified of the covenants of confidentiality set out in this Agreement. Each Party shall be liable to the other for any and all damages, including reasonable legal fees, in the event that this confidentiality provision is violated and shall be liable for any such violation by its employees, agents, professional advisors or subcontractors. On the Completion Date, any tangible Confidential Information, along with any copies thereof, shall be returned to the disclosing Party, or destroyed, at the sole option of the disclosing Party.

 

15.Indemnity by the Supplier 

 

The Supplier shall at all times and without limitation, indemnify and save harmless the Company, its, directors, officers, employees, contractors, agents and representatives from and against all liabilities, losses, costs, damages, legal fees (on a solicitor and his own client full indemnity basis), disbursements, fines, penalties, expenses, all manner of actions, causes of action, claims, demands and proceedings, all of whatever nature and kind which any of the Company, its directors, officers, employees, contractors, agents, insurers and representatives may sustain, pay or incur or which may be brought or made against all or any of them, and whether or not incurred in connection with any action or other proceedings or claims or demands made by third parties, with respect to any occurrence, event, incident or matter caused by, and/or arising as a direct or indirect result of:

 

(a)the misconduct, negligent action or negligent failure to act, as the case may be, of the Supplier and/or any of those persons for whom the Supplier is responsible at law (including, without limitation, any of its employees or contractors); or 

9

  

(b)any breach, violation or non-performance of any representation, warranty, obligation, covenant, condition or agreement in this Agreement set forth and contained on the part of the Supplier to be fulfilled, kept, observed or performed, as the case may be; or 

 

(c)any damages to third parties caused by, resulting at any time from, arising out of or in consequence of the misconduct, negligent action or negligent failure to act of the Supplier and/or any of those persons for whom the Supplier is responsible at law (including, without limitation, any of its employees or contractors). 

 

Notwithstanding the foregoing, in no event shall the Supplier be liable for consequential or punitive damages (including without limitation, loss of profits, loss of opportunity, loss of business or loss of reputation) relating to this Agreement, whether in relation to the indemnity provisions under this section or otherwise. The provisions of this Section are in addition to and shall not prejudice any other rights of the Company at law or in equity. This Section shall survive the termination or expiry of this Agreement for any reason whatsoever.

 

16.Indemnity by the Company 

 

The Company shall at all times and without limitation, indemnify and save harmless the Supplier, its, directors, officers, employees, contractors, agents and representatives from and against all liabilities, losses, costs, damages, legal fees (on a solicitor and his own client full indemnity basis), disbursements, fines, penalties, expenses, all manner of actions, causes of action, claims, demands and proceedings, all of whatever nature and kind which any of the Supplier, its directors, officers, employees, contractors, agents, insurers and representatives may sustain, pay or incur or which may be brought or made against all or any of them, and whether or not incurred in connection with any action or other proceedings or claims or demands made by third parties, with respect to any occurrence, event, incident or matter caused by, and/or arising as a direct or indirect result of:

 

(a)the misconduct, negligent action or negligent failure to act, as the case may be, of the Company and/or any of those persons for whom the Company is responsible at law (including, without limitation, any of its employees or contractors); or 

 

(b)any breach, violation or non-performance of any representation, warranty, obligation, covenant, condition or agreement in this Agreement set forth and contained on the part of the Company to be fulfilled, kept, observed or performed, as the case may be; or 

 

(c)any damages to third parties caused by, resulting at any time from, arising out of or in consequence of the misconduct, negligent action or negligent failure to act of the Company and/or any of those persons for whom the Company is responsible at law (including, without limitation, any of its employees or contractors). 

 

Notwithstanding the foregoing, in no event shall the Company be liable for consequential or punitive damages (including without limitation, loss of profits, loss of opportunity, loss of business or loss of reputation) relating to this Agreement, whether in relation to the indemnity provisions under this section or otherwise.

10

  

The provisions of this Section are in addition to and shall not prejudice any other rights of the Supplier at law or in equity. This Section shall survive the termination or expiry of this Agreement for any reason whatsoever.

 

17.Arbitration Procedure 

 

(a)All disputes, controversies or claims arising out of, relating to, or in respect of this Agreement, including a Recall Dispute or any issue regarding existence, validity, enforceability, interpretation, breach or termination of this Agreement (each a “Dispute”) shall be resolved in accordance with the terms of this Agreement. 

 

(b)Any Dispute that Parties are unable to amicably resolve or settle between themselves through negotiations between senior executives of Parties within fifteen (15) Business Days (or such longer period as the Parties may mutually agree to in writing) of a Party being provided notice of such Dispute or difference in accordance with the notice provisions of this Agreement (the “Consultation Period”) may, at the request of one of the Parties be referred to and finally determined by final and binding arbitration. For clarity, if one Party requests to proceed with arbitration, the other Party shall be required to participate, and the term of this Section 18 shall apply. The arbitration shall be confidential and shall be conducted by one independent and impartial arbitrator selected in accordance with the terms of this Agreement (the “Arbitrator”). 

 

(c)The arbitration shall be administrated by the International Court of Arbitration of the International Chamber of Commerce (the “International Court of Arbitration”) pursuant to the rules of the International Chamber of Commerce, except as they may be modified herein or by mutual written agreement of the Parties and to the extent that such rules do not conflict with the terms of Section 18. 

(d)The place of arbitration will be Vancouver, British Columbia. The language of arbitration will be English. 

 

(e)Within thirty (30) calendar days of the expiry of the Consultation Period, the Parties agree to jointly select the Arbitrator. The Arbitrator shall be impartial and independent of the Parties and shall be experienced and knowledgeable about the subject matter of the Dispute (generally and not as to the express facts concerning the Dispute). If the Parties are unable to agree upon the Arbitrator, either Party may apply to the court to select the Arbitrator. 

 

(f)The Arbitrator shall have jurisdiction: (i) to apply all Applicable Laws, common law and equity (including without limitation the scope of the agreement to arbitrate, any statute of limitations, conflict of laws rules, tort claims and interest claims); and (ii) to make an award or awards in respect of interest and the payment of the costs of the arbitration (including arbitrators’ fees and the legal costs of the Parties). The Arbitrator also may, where requested by a Party, determine the nature and extent of production of documents and oral depositions. 

11

  

(g)The award of the Arbitrator shall be reduced to writing and be final and binding on the Parties and not subject to any appeal (a “Final Determination”). Any monetary award shall be made and payable, free of any taxes or other deduction, and shall bear interest from the date of any breach or other violation of this Agreement to the date on which the award is paid, at a rate determined by the Arbitrator. 

 

(h)Judgment upon the award(s) rendered by the Arbitrator may be entered and execution had in any court of competent jurisdiction, or application may be made to such court for a judicial acceptance of the award and order of enforcement. 

(i)Each Party shall bear its own expenses of preparing for and participating in connection with the arbitration, including legal fees but the Party against whom judgment is rendered shall bear all legal fees of the Arbitrator. 

 

(j)By agreeing to arbitration, the Parties do not intend to deprive any court of its jurisdiction to issue a pre-arbitral injunction, pre-arbitral attachment or other order in aid of the arbitration proceedings and the enforcement of any award. Without prejudice to such provisional remedies in aid of arbitration as may be available under the jurisdiction of a legal court, the Arbitrator shall have full authority to grant provisional remedies, statutory remedies and to award damages for the failure of the Parties to respect the Arbitrator’s orders to that effect. 

 

(k)Nothing in this Agreement shall restrict or prohibit a Party from commencing arbitration at any time, including prior the expiry of a Consultation Period, in order to protect its rights under this Agreement or in relation to a dispute or disagreement. 

 

(l)Except as expressly provided for in this Agreement or where otherwise reasonably prevented by the nature of the Dispute, the Parties shall continue to perform their respective duties, obligations and responsibilities under this Agreement while the Dispute is being resolved in accordance with this Section 18, unless and until such obligations are lawfully terminated or expire in accordance with the provisions thereof. 

 

(m)All dispute resolution and arbitration proceedings (including all related information, communications, documents, materials, and evidence) shall be strictly confidential, and each Party shall have a fiduciary obligation to the other Party to protect, preserve and maintain the integrity of such confidentiality. 

 

18.General 

(a)Each of the Company and the Supplier will from time to time execute and deliver all such further documents and instruments and do all acts and things as the other Party may, either before or after the Completion Date, reasonably require to effectively carry out or better evidence or perfect the full intent and meaning of this Agreement. 

12

  

(b)This Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof and cancels and supersedes any prior understandings and agreements between the Parties with respect thereto. There are no representations, warranties, terms, conditions, undertakings or collateral agreements, express, implied or statutory, between the Parties other than as expressly set forth in this Agreement. 

 

(c)No amendment to this Agreement will be valid or binding unless set forth in writing and duly executed by both of the Parties. No waiver of any breach of any provision of this Agreement will be effective or binding unless made in writing and signed by the Party purporting to give the same and, unless otherwise provided, will be limited to the specific breach waived. 

 

(d)This Agreement may not be assigned by the Company or the Supplier without the written consent of the other Party. 

(e)Any demand, notice or other communication to be given in connection with this Agreement must be given in writing and will be given by personal delivery or by electronic means of communication addressed to the recipient as follows: 

To the Company:

 

Attention:Redacted 

Redacted 

Email:Redacted 

 

 

To the Supplier: 

 

Havn Life Sciences Inc 

Redacted 

Redacted 

Redacted 

 

Attention:Redacted 

Email:Redacted 

 

 

or to such other street address, individual or electronic communication number or address as may be designated by notice given by either Party to the other. Any demand, notice or other communication given by personal delivery will be conclusively deemed to have been given on the day of actual delivery thereof and, if given by electronic communication, on the day of transmittal thereof if given during the normal business hours of the recipient and on the Business Day during which such normal business hours next occur if not given during such hours on any day.

13

  

(f)The right and remedies of the Parties under this Agreement are cumulative and are in addition to, and not in substitution for, any other rights and remedies available at law or in equity or otherwise. No single or partial exercise by a Party of any right or remedy precludes or otherwise affects the exercise of any other right or remedy to which that Party may be entitled. 

 

(g)This Agreement shall be construed and governed by the laws of the Province of British Columbia and the laws of Canada applicable therein and the Parties hereto irrevocably attorn to the exclusive jurisdiction of the courts of the Province of British Columbia. 

(h)This Agreement may be executed electronically by facsimile or PDF, in any number of counterparts, each of which will be deemed to be an original and all of which taken together will be deemed to constitute one and the same instrument. 

 

(i)The invalidity or unenforceability of any particular provision of this Agreement will not affect or limit the validity or enforceability of the remaining provisions. 

 

(j)Time shall be of the essence of this Agreement. 

(k)The Parties acknowledge and agree that the provisions of this Agreement which, by their context, are meant to survive the termination of this Agreement or the passing of the Completion Date shall survive the termination of this Agreement or passing of the Completion Date and shall not be merged therein or therewith. 

 

(l)This Agreement shall enure to the benefit of and be binding upon the successors and permitted assigns of each of the Parties. 

 

(m)This Agreement shall be interpreted according to its fair construction and shall not be construed as against any Party hereto. 

 

[Remainder of Page Left Intentionally Blank]

14

  

IN WITNESS WHEREOF the Parties have executed this Agreement.

 

	 

	 

	HAVN LIFE SCIENCES INC.

	Per:

	/s/ Tim Moore

	 

	Name: Tim Moore

	 

	Title:CEO 

 

	 

	 

	MYCOTOPIA THERAPIES INC.

	Per:

	/s/ Benjamin Kaplan

	 

	Name: Benjamin Kaplan

	 

	Title: CEO

15

SCHEDULE A 
The Material

 

	Drug Substance

	Form

	Strength

	Unit Size

	Purchase Price per Unit (USD) 

	Psilocybin (GMP)

	API

	N/A

	[l] grams

	[l]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]